AMOY DIAGNOSTICS
Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular diagnostic assays. Based on multiple technology platforms including PCR, NGS, FISH and IHC, AmoyDx's core product categories include single gene testing kits, multi-gene testing panels, NGS panels, and NGS analytical systems.
AMOY DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical Oncology Pharmaceutical Precision Medicine
Founded:
2008-01-01
Address:
Xiamen, Fujian, China
Country:
China
Website Url:
http://www.amoydx.com
Total Employee:
1001+
Status:
Active
Contact:
+86 592 680 6835
Email Addresses:
[email protected]
Total Funding:
164.24 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network Pound Sterling Japanese Yen China Ministry Of Public Security CNZZ
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
MTAMTech Corp
Anti-cancer drug screening solution for application in personalized medicine and drug development
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series B - Amoy Diagnostics
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Amoy Diagnostics
Official Site Inspections
http://www.amoydx.com Semrush global rank: 8.25 M Semrush visits lastest month: 595
- Host name: 8.218.7.26
- IP address: 8.218.7.26
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "Amoy Diagnostics"
AmoyDx
Organization: Telephone: Country: ... AmoyDx is excited to be part of this incredible gathering for oncology community. Our team has been all geared up to engage with you at booth #520, hall …See details»
Our Company - [AmoyDx] - Amoy Diagnostics
Welcome to AmoyDx. A visionary diagnostic company dedicated to transforming the landscape of cancer care. 'Breaking Barriers to Precision Oncology' reflects our commitment to revolutionizing cancer diagnosis and treatment.See details»
Global Presence - [AmoyDx] - Amoy Diagnostics
Organization: Telephone: Country: ... Login. Global Distributor Network. AmoyDx has been focusing on companion diagnostics for nearly 20 years. A worldwide network has been soundly established to deliver our commitment to advancing …See details»
Amoy Diagnostics - Crunchbase Company Profile & Funding
Amoy Diagnostics is a research and development based diagnostic company focusing on molecular diagnostics for oncology precision medicine. AmoyDx has a portfolio of molecular …See details»
AmoyDx
Better life with AmoyDx 了解更多 ; 诚信 责任 创新 合作 Honesty Responsibility Innovation Cooperation 了解更多 ; 知而治之 · 艾德相伴 Better life with AmoyDx 了解更多 ; 诚信 责任 创新 …See details»
Amoy Diagnostics - LinkedIn
Amoy Diagnostics | 4,549 followers on LinkedIn. Breaking Barriers to Precision Oncology | Amoy Diagnostics (AmoyDx) is a visionary diagnostic company dedicated to transforming the landscape of ...See details»
AmoyDx and CST Expand Existing Partnership for the …
Nov 23, 2023 “AmoyDx’s industry-leading molecular diagnostics and clinical services are at the forefront of innovation, and our ongoing partnership will help move precision oncology forward by providing ...See details»
AmoyDx Enters into Master Collaboration Agreement with …
Apr 18, 2022 The AmoyDx decentralized CDx are based on the HANDLE ® system, a proprietary NGS library construction technology developed by AmoyDx, that can enable the …See details»
NGS Technology - [AmoyDx] - Amoy Diagnostics
Organization: Telephone: Country: ... AmoyDx dual-directional capture (ddCapture) technology is a proprietary capture-based approach that utilizes biotinylated oligonucleotide baits (probes) to hybridize to regions of interest, …See details»
AmoyDx and PREMIA Announce the Commercial Launch of the
Jan 13, 2022 AmoyDx has a portfolio with more than twenty products approved by China’s NMPA, the EU regulatory authorities, Japan’s MHLW, South Korea’s MFDS, etc. Patients in …See details»
AmoyDx, AstraZeneca partner for multiple companion diagnostics
Apr 19, 2022 The AmoyDx decentralised CDx is based on the HANDLE system, a patented NGS library building technique created by AmoyDx that can perform HRR or BRCA gene …See details»
AmoyDx Enters into Master Collaboration Agreement with …
Apr 18, 2022 Li-Mou Zheng, Ph.D., Founder and Chairman of AmoyDx, commented: “We are very pleased to announce today that we are further developing our partnership with …See details»
AmoyDX and AstraZeneca Enter Master Collaboration Agreement
Apr 18, 2022 Amoy Diagnostics Co. (AmoyDx), a China-based molecular diagnostics company, announced on April 18, 2022 that it has entered into a Master Collaboration Agreement with …See details»
AmoyDx Enters into Master Collaboration Agreement with
Apr 18, 2022 AmoyDx has a market-leading portfolio of molecular tests and is the therapy diagnostics partner for several major multinational pharmaceutical companies offering …See details»
AmoyDx ® Master Panel - Amoy Diagnostics
Organization: Telephone: Country: ... The AmoyDx Master Panel facilitates the concurrent detection of both DNA and RNA biomarkers. On the DNA level, it encompasses 571 genes, …See details»
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval …
Jun 30, 2021 (1) Product name. AmoyDx® Pan Lung Cancer PCR Panel (2) Approval No. 30300EZX00059000 (3) Purpose of use. Detection of EGFR gene mutations, ALK fusion …See details»
Products - [AmoyDx] - Amoy Diagnostics
AmoyDx ® Essential NGS Panel The assay is tailored to detect prevalent mutations in 10 genes: EGFR, ALK, ROS1, RET, KRAS, NRAS, PIK3CA, BRAF, HER2, and MET, in patients with …See details»
AmoyDx® Pan Lung Cancer PCR Panel Receives MHLW Approval as
Jun 30, 2021 (1) Product name: AmoyDx® Pan Lung Cancer PCR Panel (2) Approval No. 30300EZX00059000 (3) Purpose of use: Detection of EGFR gene mutations, ALK fusion …See details»
Now available: The AmoyDx ® Myeloid Blood Cancer Panel
The AmoyDx ® Myeloid Blood Cancer Panel is a Next-Generation Sequencing-based assay for the detection of mutations (SNVs), insertions and deletions (InDels) as well as fusions in 55 …See details»
PCR Technology - [AmoyDx] - Amoy Diagnostics
Organization: Telephone: Country: ... AmoyDx ® Automated Result Analysis System (ARAS), an advanced software designed to automate the interpretation of AmoyDx PCR data, elevating …See details»